Company:  NEXIEN BIOPHARMA, INC. (NXEN)
Form Type:  3
Filing Date:  11/8/2018 
CIK:  0001625288 
Address:  4340 E KENTUCKY AVE
SUITE 206
 
City, State, Zip:  GLENDALE, Colorado 80246 
Telephone:  (303) 495-7583 
Fiscal Year:  06/30 
Last Trade
Last Trade: 
$0.19  
Change: 
0.00 (-0.11%)  
Trade Time: 
10:51 AM EST  
Market Cap: 
$10.54M
Trade NXEN now with

© 2018  
Description of Business
In this report, unless the context requires otherwise, references to the "Company", "BioPharma", "we", "us" and "our" are to Nexien BioPharma, Inc., a Delaware corporation, formerly Intiva BioPharma Inc. Corporate History The Company was incorporated on November 10, 1952 in Michigan as Gantos, Inc. On July 21, 2008, the Company completed its change in domicile to Delaware and subsequently changed its name to Kinder Holding Corp. Since bankruptcy liquidation in June 2000, the Company has not had any operations and adopted "fresh-start" accounting as of June 21, 2000 in accordance with procedures specified by AICPA Statement of Position No. 90-7, "Financial Reporting by Entities in Reorganization under the Bankruptcy Code." As of October 13, 2017, the Company completed a reverse acquisition (the "Share Exchange Transaction") of Intiva BioPharma Inc., a private Colorado corporation ("Colorado BioPharma").
Register and access this filing in:     
  FORM 3
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES